Bond.az White LogoBond.az Black Logo

TD Cowen Reiterates Hold on Infosys, $13 Target

TD Cowen analyst reiterates Hold rating on Infosys with $13 target. AI impacts and market dynamics in focus.

Isabella Martinez
ByIsabella Martinez- Senior Editor
|
0

TD Cowen analyst Bryan Bergin reiterated a Hold rating and $13.00 price target on Infosys Technologies (NYSE:INFY). The stock currently trades at $11.66, near its 52-week low of $11.55, reflecting a challenging year with shares down 36%.

The firm hosted Sandeep Mahindroo, Controller & Head of IR, for investor meetings. Key topics included enterprise demand, competitive intensity, AI impacts and opportunities, organic investments, and capital allocation.

Infosys remains guarded on the near-term outlook as discretionary spending stays muted and decision cycles slowed in late March and April due to Iran uncertainty. AI-driven deflation is becoming more visible.

The company's positive medium-term view is unchanged, based on six key AI value pools: data, modernization, process/agentification, and governance. It believes these will outstrip AI deflation over the medium to long term. However, a timing gap exists as FY27 growth remains muted.

TD Cowen expects continued scrutiny on volume/revenue conversion, discretionary softness, and AI-driven commercial pressure in the near term.

More News
Today / 07:01
|
209

Morgan Stanley Downgrades Aegon Stock Rating

Morgan Stanley downgrades Aegon stock to Equalweight, citing limited upside after a 20% rally. Price target remains EUR 7.00.

0
Yesterday / 18:30
|
683

Morgan Stanley hikes Sunnova stock price target

Morgan Stanley increased Sunnova price target to $494 with a 36x multiple, citing strong execution and growth prospects.

0
Yesterday / 18:02
|
892

Evercore ISI Raises HP Enterprise Target on H3C Sale

Evercore ISI raised HP Enterprise price target to $40 after H3C stake sale for $986.8 million. HPE stock near 52-week high.

0
Yesterday / 16:32
|
824

Guggenheim Raises StubHub Target on Strong Q1

Guggenheim lifted StubHub's price target after strong Q1 results, citing revenue and EBITDA beats.

0
Yesterday / 13:34
|
741

Jefferies Reiterates Buy on Biogen Stock

Jefferies reiterates Buy rating on Biogen stock with $210 target following promising Phase II Alzheimer's data.

0
Yesterday / 13:32
|
873

Marvell price target raised to $200 by RBC on optical strength

RBC Capital raised Marvell Technology price target to $200, citing optical business strength. AI networking and custom XPU trends support growth.

0
Yesterday / 13:03
|
769

Morgan Stanley Upgrades Assurant Stock Rating

Morgan Stanley upgrades Assurant stock to Overweight, raises price target to $285. Strong earnings and growth outlook highlighted.

0
Yesterday / 12:41
|
890

Biogen Stock Rises as Stifel Maintains Buy

Biogen stock rises as Stifel maintains buy rating. Updates on Alzheimer's drug trial and financial results.

0
Yesterday / 12:32
|
422

Compass Point raises Nebius target to $260 on strong Q1

Compass Point raised Nebius price target to $260 on strong Q1 results. ARR and AI Cloud revenue surge. Read more on Bond.az.

0
Yesterday / 11:44
|
476

H.C. Wainwright Reiterates Immunic Stock Rating

H.C. Wainwright maintains Buy rating and $22 price target on Immunic stock. The company awaits pivotal MS drug trial results. Read more on Bond.az.

0
Yesterday / 11:43
|
801

H.C. Wainwright Reiterates Kamada Buy Rating

H.C. Wainwright reaffirms Buy rating on Kamada with $13 target. Kamada expects double-digit revenue growth in 2026.

0
Yesterday / 11:42
|
903

Titan Mining Price Target Cut by H.C. Wainwright

H.C. Wainwright cuts Titan Mining price target to $6.50, maintains Buy. Stock up 357% in a year, but Bond.az flags overvaluation risk.

0
...